Back to Course

MEDD Live 2020 Virtual Medical Conference

0% Complete
0/0 Steps
  1. Week One: 1st - 2nd August
    18 Topics
  2. Week Two: 8th - 9th August
    18 Topics
  3. Week Three: 15th - 16th August
    15 Topics
  4. Week Four: 22nd August
    9 Topics
Lesson 1, Topic 5
In Progress

Coronary Microvascular Dysfunction – How Technology Helps Drive Treatment. Presented by Dr Yohan Chacko

Lesson Progress
0% Complete
THIS TALK WAS PRESENTED LIVE DURING THE INAUGURAL MEDD LIVE 2020 VIRTUAL MEDICAL CONFERENCE

Coronary Microvascular Dysfunction – How Technology Helps Drive Treatment

Learning Objectives: 
1. What is microvascular angina?
2. What is coronary vasospasm?
3. How to test for this?
4. Benefits of testing
5. Differences in the management of these conditions

Abstract:
>50% of women with angina referred for coronary angiography have non-obstructive coronary arteries. Most are labelled as non-cardiac chest pain or given an empirical diagnosis of microvascular dysfunction. Progress in research and medical technology have now made it easier to definitively diagnose microvascular angina and coronary vasospasm. Randomised controlled trial results have shown improvements in symptoms and quality of life by performing these invasive tests and making a definitive diagnosis with tailored treatment. Coronary microvascular and vasospasm testing is now available at CardioVascular Clinics.

>

We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By using MEDD, you consent to our use of cookies. To find out more about the cookies we use, please see our Privacy Policy